MELORMED
ActiveSummary
MELORMED has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €27,758 and a net result of €25,617. Its solvency ranks better than 28% of 20,330 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).